| abstract |
The present invention relates to a stable liquid pharmaceutical preparation for an anti-influenza virus antibody and, more specifically, to a stable liquid pharmaceutical preparation containing: (A) an anti-influenza virus antibody or a mixture of two or more different types of anti-influenza virus antibodies; (B) a surfactant; (C) a sugar or a sugar derivative; and (D) an amino acid. The stable liquid pharmaceutical preparation for an anti-influenza virus antibody of the present invention has excellent storage stability at low temperature (5°C), room temperature (25°C), and high temperature (40°C) and excellent long-term (12 months) storage stability, and can be administered intravenously, intramuscularly, intradermally, subcutaneously, intraperitoneal-locally, or in combinations thereof. |